Trial intelligence / Profile preview

Omega-3 and Eyelid Cleansers for Pediatric Chalazia

NCT07496515Phase 2Not yet recruiting

Sponsor
Jaeb Center for Health Research
Start
Feb 2027
Primary completion
Oct 2027
Modality
Small Molecules
01

Overview

Phase 2, randomised, single-blind trial in chalazion (3 arms), sponsored by Jaeb Center for Health Research. Primary endpoints: Improvement or resolution of chalazia at 8 weeks and Proportion of participants with new chalazia at 12 months. Planned start Feb 2027; status: not yet recruiting.

02

Conditions

chalazion

Beyond the preview

Go deeper on NCT07496515.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07496515.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call